Hyperliquid has faced a potential 10-to-12-month regulatory process to enter the U.S.
Silver Price Forecast: XAG/USD consolidates below 100-Day SMA as momentum fades
ONEOK's $4.425B Brazos Midland deal more than double Midland Basin processing capacity and expand its Permian footprint.
With LSTR shares moving north, we assess the current positioning of the stock to determine if it's a good investment at this juncture.
ExxonMobil's record Q2 production and $116B revenue beat highlight growth, but costs, cyclicality and Middle East disruptions cloud earnings visibility.
SoundHound AI's SOUN healthcare business is emerging as a potentially important growth driver as enterprises increasingly adopt conversational and agentic AI for complex customer-service workflows. In the second quarter of 2026, SoundHound signed a seven-figure deal with a nationally ranked healthcare system employing 30,000 people.
DY sees BEAD construction ramping in 2027, opening a roughly $17 billion addressable market alongside strong fiber-to-the-home growth.
Snowflake heads into Q2 earnings with strong AI momentum and customer growth, though premium valuation and margin pressures remain risks.
Two days after the biggest quarter in semiconductor history, macro investor Jordi Visser told listeners on The Pomp Podcast that the scarcity holding up NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) has an expiration date.
GameStop's $55.5 billion eBay swing rattled the stock, but a partnership could preserve much of the strategic upside without forcing shareholders to swallow the whole deal. Beneath the EBAY noise, the old retailer is finally showing some teeth: operating profits are climbing even as revenue keeps shrinking. The dilution sting is still real, but the 55.5 million-share exchange finally puts a number on what had been an open-ended overhang.
Micron Technology, Inc. is transforming from a cyclical memory supplier to a mission-critical AI infrastructure provider, underpinned by historic Q3 FY2026 results. MU's growth is driven by surging demand for high-bandwidth memory (HBM), multi-year strategic customer agreements, and persistent supply constraints supporting pricing power. Long-term purchase commitments now cover about half of revenue, providing durable visibility and supporting disciplined capacity expansion and margin sustainability.
10x Genomics wins a $4.8M patent verdict against Parse, strengthening its IP position as it seeks added damages and a U.S. injunction.
ARHS is pairing product innovation and customization with its signature design aesthetic to deepen luxury customer appeal.
Russia's new crypto rules start Sept. 1 as Sberbank forecasts $46B in first-year regulated trading and prepares crypto-backed loans.
Cronos restored its blockchain to before the Tectonic exploit, although 2,592 ETH reportedly remained outside the network.
Dogecoin price fell 2.48% on August 31, trading near $0.082 as rising selling pressure weighed on the popular meme coin. Retail traders appear to be locking in profits following recent gains, while DOGE is now testing an important technical support level.
Alphabet's stock took off last year after the company got a legal settlement out of the way, and now Meta's stock is looking at a similar setup.
PPL's rising operating income, data center demand, rate recovery and $23B investment outlook support 6-8% annual EPS growth through 2029.
BOOT's work business is accelerating as merchandising, marketing and brand investments drive five straight quarters of growth.
After outperforming its benchmark in 1Q2026, the Nomura Value Fund Institutional Class shares lost considerable ground to the Russell 1000® Value Index in 2Q2026. Positive stock selection results in the communication services and materials sectors were leading contributors for the quarter. During the quarter, we made two full-position sales while initiating six new positions in the Strategy.
An attacker drained approximately $234,000 from a legacy Balancer V1 liquidity pool on August 31, 2026. The vulnerability allowed the minting of 4,408.8 BPT tokens by depositing just a single satoshi after compressing WBTC reserves. The attack utilized nested flash loans from platforms such as Aave, Spark, Morpho, and Uniswap V3.
A prolific hacking group has taken credit for last week's cyberattack against U.S. pharmaceutical distribution giant McKesson, leading to the latest spill of highly sensitive health data by an American healthcare company in recent months.
Farm equipment stocks caught a bid Monday afternoon after Baird upgraded both Deere (NYSE:DE | DE Price Prediction) and AGCO (NYSE:AGCO) on North America row crop demand. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.5% to $765.
Energy stocks have already had a strong 2026, but investors looking at the Direxion Daily Energy Bull 2X Shares (NYSEARCA:ERX) do not necessarily need Exxon Mobil, Chevron, or the broader energy sector to double from here for the ETF to
FirstEnergy edges PPL on ROE, capital spending, valuation and one-year share performance, despite carrying a higher debt-to-capital ratio.
Crypto-linked equities are climbing midday Monday even as Bitcoin (CRYPTO:BTC) and Ethereum (CRYPTO:ETH) trade lower over the past 24 hours.
Ormat is a Buy with a $122 target, supported by raised 2026 guidance and a stable contracted electricity base. Q2 revenue rose 10.6% and adjusted EBITDA 6.9%, while full-year guidance increased to $1.15-$1.20B in revenue and $630-$650M in adjusted EBITDA. Storage revenue nearly tripled to $42.8M, though margins should normalize in H2.
Bitmine Immersion Technologies (BMNR) accelerated its Ethereum accumulation for a second consecutive week, purchasing another 53,501 ETH as Chairman Tom Lee expects strong crypto market performance to attract greater institutional demand. The latest Ethereum purchase was valued at approximately $131.3 million based on an ETH price of around $2,455 on Monday.
Boeing saw stable net orders year-on-year in July, with 30 net orders valued at $3.3 billion, despite overall order inflow slowing. BA's July deliveries fell sequentially to 53 units but remained robust, up 10% year-over-year, reflecting stable operational output. Order mix improved, driving higher order value; book-to-bill ratios for the year remain strong at 1.3x (units) and 1.7x (value).
Protagonist Therapeutics NASDAQ: PTGX said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV.